Asthma is a clinical condition that has only recently been considered a risk factor for the development of pneumococcal infections. In the most recent guidelines concerning the use of pneumococcal vaccines, the Advisory Committee on Immunisation Practices recommends pneumococcal vaccination only when children with asthma aged <71 months are treated with high-dose corticosteroids, whereas the same Committee clearly indicates that asthma (without any definition of severity or treatment) is a reason for systematic pneumococcal vaccination in adults. It is also unclear which pneumococcal vaccine should be used and how to face the problem of booster doses. The main aim of this paper is to describe what is known about the real risk of pneumococcal infections in children with asthma, and discuss the unsolved problems regarding the paediatric use of pneumococcal vaccines. There are few published data regarding pneumococcal colonisation and the burden of pneumococcal disease in asthmatic children and adolescents, and none at all concerning the relationship between paediatric asthma and immune responses to pneumococcal vaccines. Further studies are therefore essential to assure that children and adolescents with asthma receive the best protection against pneumococcal diseases.
Paediatric asthma and pneumococcal vaccination / S. Esposito, A. Musio, N. Principi. - In: VACCINE. - ISSN 0264-410X. - 31:44(2013 Oct 17), pp. 5015-5019.
|Titolo:||Paediatric asthma and pneumococcal vaccination|
ESPOSITO, SUSANNA (Primo)
PRINCIPI, NICOLA (Ultimo)
|Parole Chiave:||Adolescents ; Asthma ; Children ; Pneumococcal conjugate vaccine ; Pneumococcal vaccine ; Streptococcus pneumoniae|
|Settore Scientifico Disciplinare:||Settore MED/38 - Pediatria Generale e Specialistica|
|Data di pubblicazione:||17-ott-2013|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.vaccine.2013.08.090|
|Appare nelle tipologie:||01 - Articolo su periodico|